Skip to content

Evaluation of Group CBT Programme With Breast Cancer Patients

An Evaluation of a Group CBT Programme for Women With Primary Breast Cancer.

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00426335
Enrollment
78
Registered
2007-01-24
Start date
2007-01-31
Completion date
Unknown
Last updated
2010-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Keywords

breast, cancer, cognitive behaviour therapy, psychological

Brief summary

The purpose of this study is to examine whether a group CBT intervention is effective in reducing psychological distress in women with primary breast cancer.

Detailed description

The diagnosis and treatment of cancer is associated with high levels of psychological distress, which can be long-term in duration. The end of adjuvant therapy can be a time which patients find anxiety provoking; as concerns of recurrence and how to return to life after treatment often arise at this juncture. Cognitive behaviour therapy has demonstrated efficacy in reducing anxiety and depression in people with cancer on a 1:1 basis. The CBT model has been shown to be significantly more beneficial than supportive counselling. Therapy delivered in groups is considered desirable because of its cost effectiveness, and its potential to confer additional benefits in terms of peer support, reduced isolation and modelling of adaptive strategies by other group members. No studies have looked at the changes in participants health beliefs and beliefs about their ability to copy (self-efficacy) with stress and tolerance of uncertainty following group CBT and the relationship with psychological distress. The aim of this study is to evaluate a GCBT programme intervention against a waiting list control and to examine its effects on health beliefs, self-efficacy, coping, tolerance of uncertainty and psychological distress in women with early diagnosed breast cancer.

Interventions

None listed

Sponsors

Royal Marsden NHS Foundation Trust
Lead SponsorOTHER

Study design

Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Female * Primary breast cancer * post adjuvant treatment

Exclusion criteria

* Women with metastatic disease * Severe cognitive impairment (will not be able to obtain consent or participant in group intervention) * Inability to complete a questionnaire

Countries

United Kingdom

Contacts

Primary ContactMaggie Watson, Dr
maggie.watson@rmh.nhs.uk020 8661 3009
Backup ContactMary Burgess
mary.burgess@rmh.nhs.uk020 7808 2777

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026